biomedicina slovenica

hypercoagulability : 21

  1. Gerotziafas Grigoris T.; Catalano Mariella; Colgan Mary-Paula; Pecsvarady Zsolt; Wautrecht Jean-Claude; Fazeli Bahare; Olinic Dan Mircea; Kozak Matija; Poredoš Pavel; Šuput Dušan
    Guidance for the Management of Patients with vascular disease or cardiovascular risk factors and COVID-19
    2020 ►
  2. Nedog Viljemka
    Dejavniki tveganja za nastanek globoke venske tromboze
    2007 ►
  3. Božič Mojca; Boc Vinko; Salapura Vladka; Blinc Aleš; Stegnar Mojca
    Is restenosis/reocclusion after femoropopliteal percutaneous transluminal angioplasty (PTA) the consequence of reduced blood flow, inflammation, and/or hemostasis disturbances?
    2015 ►
  4. Božič Mojca; Boc Vinko; Salapura Vladka; Blinc Aleš; Stegnar Mojca
    Is restenosis / reocclusion after femoropopliteal percutaneous translumnal angioplasty (PTA) the consequence of reduced blood flow, inflammation, and / or hemostasis disturbances?
    2015 ►
  5. Žerjavič Katja; Zagradišnik Boris; Lokar Lidija; Kokalj-Vokač Nadja
    An aquired JAK2 V617F mutation in patients with hypercoagulability disorder
    2009 ►
  6. Anžej Saša; Vučnik Maja; Božič Mojca; Peternel Polona; Stegnar Mojca
    Enhanced thrombin generation in women with a history of oral contraception-related venous thrombosis
    2013 ►
  7. Takač Iztok; Kupnik Dejan; Fokter Nina
    Venska trombembolija pri bolnicah z rakom jajčnikov
    [Venous tromboembolism in patients with ovarian cancer]
    2010 ►
  8. Urlep-Šalinović Veronika
    Razvojna pot transfuzijske dejavnosti v Mariboru
    [Development of transfusiology in Maribor]
    2010 ►
  9. Žerjavič Katja; Zagradišnik Boris; Lokar Lidija; Kokalj-Vokač Nadja
    An aquired JAK2 V617F mutation in patients with hypercoagulability disorder
    2009 ►
  10. Frank Mojca; Sodin-Šemrl Snežna; Rozman Blaž; Potočnik Marko; Kralj-Iglič Veronika
    Effects of low-molecular-weight heparin on adhesion and vesiculation of phospholipid membranes: a possible mechanism for the treatment of hypercoagulability in antiphospholipid syndrome
    2009 ►
  11. Anžej Saša; Božič Mojca; Antovič Aleksandra; Peternel Polona; Gašperšič Nataša; Rot Uroš; Tratar Gregor; Stegnar Mojca
    Evidence of hypercoagulability and inflammation in young patients long after acute cerebral ischaemia
    2007 ►
  12. Stegnar Mojca; Vižintin-Cuderman Tjaša; Božič Mojca
    Evaluation of pre-analytical, demographic, behavioural and metabolic variables on fibrinolysis and haemostasis activation markers utilised to assess hypercoagulability
    2007 ►
  13. Thomas Robert H
    Sindromi hiperkoagulabilnosti
    [Hypercoagulability syndromes]
    2003 ►
  14. Peternel Polona
    Ali antikoagulacijsko zdravljenje vpliva na prognozo raka?
    2006 ►
  15. Peternel Luka; Stegnar Mojca; Drevenšek Gorazd; Budihna Metka V; Božič Mojca; Zega Anamarija; Štalc Anton; Černe Manica; Urleb Uroš
    Antithrombotic potential of new direct thrombin inhibitors built on the azaphenylalanine scaffold in two rat venous thrombosis models
    2005 ►
  16. Urlep-Šalinović Vera
    Laboratorijska diagnostika hemostatskih motenj v porodništvu
    2004 ►
  17. Mušič P; Šoštarič M
    A case report of patient with antiphospholipid syndrome
    2003 ►
  18. Salobir B; Šabovič M; Peternel P; Stegnar M; Grad A
    Classic risk factors, hypercoagulability and migraine in young women with cerebral lacunar infarctions
    2002 ►
  19. Fras Zlatko
    Spremembe v mikrocirkulaciji pri sladkorni bolezni
    [Microcirculatory alterations in diabetes mellitus]
    2001 ►
  20. Meglič Leon
    Genetski dejavniki tveganja pri venski trombozi v nosečnosti in puerperiju
    2000 ►
  21. Fras Zlatko
    Spremembe v mikrocirkulaciji pri sladkorni bolezni
    [Changes in microcirculation in diabetes mellitus]
    1996 ►


New search      Comments      Top of page Institute for Biostatistics and Medical Informatics